| 摘要 |
Compounds of formula (I) are inhibitors of peptide binding to major histocompatibility complex type II proteins and are useful in the treatment and prevention of autoimmune diseases including: rheumatoid arthritis, Type I diabetes, multiple sclerosis, lupus erythematosis, Graves disease and pemphigus. The present invention also provides novel compositions, methods of treatment employing the compounds of the present invention and methods of manufacture of the compounds of structural formula (I).
|
| 申请人 |
MERCK & CO., INC.;ACTON, JOHN, J., III;ADAMS, ALAN, D.;HERMES, JEFFREY, D.;JONES, A., BRIAN;PARONS, WILLIAM, H.;SINCLAIR, PETER, J. |
发明人 |
ACTON, JOHN, J., III;ADAMS, ALAN, D.;HERMES, JEFFREY, D.;JONES, A., BRIAN;PARONS, WILLIAM, H.;SINCLAIR, PETER, J. |
